learn Pyrilutamide
highly targeted anti-androgen that might have minimal systemic effects
- What is pyrilutamide, and how does it help with androgenic alopecia or hair loss caused by DHT? Pyrilutamide (KX-826) is an investigational topical antiandrogen designed to block DHT at the androgen receptor in the scalp rather than lower DHT in the blood. Its sponsor has announced positive Phase III top-line results in China, but none of the data are peer-reviewed and it is not approved as a medicine anywhere.
- Can pyrilutamide be used by both men and women, or only in specific cases? Pyrilutamide (KX-826) is an investigational topical anti-androgen that has been trialled in both men and women, but it is not approved for hair loss anywhere; the company reports that its China Phase III trial in men met its primary endpoint, but the data come from sponsor announcements rather than peer-reviewed journals, and long-term safety is unknown.
- How long does it take to see visible results when using pyrilutamide topically? No published trial reports when pyrilutamide users first notice a change; its sponsor's studies measured results at 24 weeks, and all of those figures come from company announcements rather than peer-reviewed papers. Pyrilutamide is an unapproved experimental compound.
- All 4 questions on Pyrilutamide →
